Korro Bio, Inc. (KRRO)
NASDAQ: KRRO · Real-Time Price · USD
50.62
+3.62 (7.70%)
At close: Nov 21, 2024, 4:00 PM
50.82
+0.20 (0.40%)
After-hours: Nov 21, 2024, 4:27 PM EST

Korro Bio Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2023 FY 2022 FY 2021
Period Ending
Sep '24 Dec '23 Dec '22 Dec '21
Net Income
-87.81-81.17-58.03-21.96
Depreciation & Amortization
3.33.632.511.6
Loss (Gain) From Sale of Assets
0.070.07-0.01
Loss (Gain) From Sale of Investments
-1.16-0.08-0.150.02
Stock-Based Compensation
4.332.381.140.81
Other Operating Activities
4.373.611.51-13.47
Change in Accounts Payable
2.063.11.760.06
Change in Unearned Revenue
----0.69
Change in Other Net Operating Assets
1.171.18-2.391.53
Operating Cash Flow
-73.69-67.28-53.65-32.09
Capital Expenditures
-18.11-7.84-5.21-4.45
Sale of Property, Plant & Equipment
---0.01
Investment in Securities
-104.131916.27-35.07
Investing Cash Flow
-122.2411.1611.06-39.5
Issuance of Common Stock
222.63154.550.060.03
Other Financing Activities
-9.62-12.25-0.04-0.03
Financing Cash Flow
213.01187.760.02115.95
Net Cash Flow
17.09131.64-42.5744.35
Free Cash Flow
-91.79-75.12-58.86-36.54
Free Cash Flow Per Share
-11.62-49.12-230.65-8.22
Cash Income Tax Paid
0.050.030.01-
Levered Free Cash Flow
-78.02-47.69-38.2-
Unlevered Free Cash Flow
-78.02-47.69-38.2-
Change in Net Working Capital
7.7-6.97-0.24-
Source: S&P Capital IQ. Standard template. Financial Sources.